Diabetic Pathophysiology

Type2 diabetes mellitus is characterized by a both combinations of inadequate insulin secretion by pancreatic beta cells and peripheral insulin resistance. Insulin resistance, which has been associate to proinflammatory cytokines in plasma  and elevated levels of free fatty acids, it leads to decreased glucose transport into muscle cells, elevated hepatic glucose production, and increased breakdown of fat. The major role for excess glucagon cannot be underestimated; indeed, Type2 diabetes (T2D)  is an islet paracrinopathy in which the reciprocal relationship between the insulin-secreting beta cell and the glucagon-secreting alpha cell is lost, which leads to hyperglucagonemia and hence the consequent hyperglycaemia. For type 2 diabetes mellitus (T2DM) to occur, both insulin resistance and inadequate insulin secretion must exist. Generally all overweight or obese individuals have insulin resistance, but diabetes develops only in those individuals who cannot raise insulin secretion to that level so that it can compensate for their insulin resistance. Their insulin concentrations may be high, which results in low level of glycaemia.

  • Acute pancreatitis symptoms
  • Identification of β-cell dysfunction and insulin resistance
  • Differentiation of diabetes by pathophysiology, natural history
  • Clinical features of diabetes mellitus

Related Conference of Diabetic Pathophysiology

September 16-17, 2019

International Conference on Diabetes and Heart diseases

Athens, Greece
September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
Nov 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
November 25-26, 2019

Annual Congress on Endocrinology, Diabetes and Healthcare

Bangkok,Thailand
December 02-03, 2019

14th European Diabetes and Endocrinology Congress

| Barcelona, Spain
Diabetes Congress 2019 | December 04-05, 2019 |

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

| Dubai, UAE
January 29-30, 2020

Global Summit On Diabetes & Endocrinology

| Holiday Inn Atrium | Singapore
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan

Diabetic Pathophysiology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in